Internal Medicine, Endocrinology, Diabetes, & Metabolism · Kansas City, MO
NPI
1700059540
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2301 Holmes St
Kansas City, MO, 64108
Phone (816) 404-4070
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,665
125 services
Medicare patients, 2024
63
Average age 66
Drug cost, 2024
$963K
2,119 prescriptions
Company payments, 2025
$162
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maha Abu Kishk was code 99214 (office e&m - established), 97 times for 52 patients. In total Maha Abu Kishk billed 125 services in 6 codes, and Medicare paid $8,665.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 97 | 52 | $68.53 | $6,647 |
| 99204 Office E&M - New | Facility | 12 | 12 | $102.11 | $1,225 |
By year: 2022 $8,347 for 120 services; 2023 $8,709 for 118 services; 2024 $8,665 for 125 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maha Abu Kishk prescribed most often to Medicare patients was Trulicity (Dulaglutide), with 227 prescriptions and refills. In total Maha Abu Kishk wrote 2,119 Medicare prescriptions that cost $963K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trulicity Dulaglutide | 227 | 268 | 37 | $262K |
| Levothyroxine Sodium Generic | 199 | 437 | 48 | $1,729 |
| Ozempic Semaglutide | 175 | 221 | 31 | $211K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 110 | 257 | 46 | $24K |
| Mounjaro Tirzepatide | 97 | 110 | 20 | $117K |
| Metformin Hcl Generic | 88 | 194 | 23 | $340 |
| Atorvastatin Calcium Generic | 82 | 178 | 22 | $589 |
| Farxiga Dapagliflozin Propanediol | 77 | 147 | 22 | $83K |
| Jardiance Empagliflozin | 72 | 122 | 16 | $72K |
| Humalog Kwikpen U-100 Insulin Lispro | 64 | 109 | 18 | $23K |
| Metformin Hcl Er Metformin Hcl | 61 | 99 | 13 | $815 |
| Lisinopril Generic | 47 | 110 | 16 | $327 |
| Glimepiride Generic | 42 | 62 | Under 11 | $223 |
| Losartan Potassium Generic | 38 | 104 | 13 | $185 |
| Pregabalin Generic | 38 | 50 | 11 | $1,933 |
Brand drugs: 1,147 claims; generic drugs: 827 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maha Abu Kishk $162 ($162 in general payments such as food, travel and fees) from 2 companies. The largest payer was Tandem Diabetes Care, Inc. with $143.
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. TNDM | 1 | $143 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.